Ian Karp
Public Communications Contact presso INTELLIA THERAPEUTICS, INC.
Posizioni attive di Ian Karp
Società | Posizione | Inizio | Fine |
---|---|---|---|
INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - | - |
Storia della carriera di Ian Karp
Precedenti posizioni note di Ian Karp
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHIRE | Contatto Relazioni con gli Investitori | 01/03/2016 | 01/12/2017 |
Corporate Officer/Principal | 01/01/2012 | 01/01/2016 | |
Medimmune, Inc. | Vendite & Marketing | - | - |
KARYOPHARM THERAPEUTICS INC. | Contatto Relazioni con gli Investitori | 25/07/2018 | - |
Public Communications Contact | 25/07/2018 | - |
Formazione di Ian Karp
Emory University | Undergraduate Degree |
Rutgers Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Irlanda | 2 |
Posizioni
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
INTELLIA THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Medimmune, Inc. | Health Technology |
- Borsa valori
- Insiders
- Ian Karp
- Esperienza